Lightbeam Marketplace Partner

CareSignal leverages Lightbeam’s industry leading risk-stratification solutions to identify the 10-30% of a population that qualifies as “rising-risk,” and works with your team to generate a list of eligible patients.

CareSignal’s enrollment team reaches out on behalf of your organization to educate, enroll, and activate patients on the white-labeled program.
Once enrolled, patients engage with CareSignal condition-specific programs such as CHF, COPD, Diabetes, Hypertension, Depression, and dozens more. Each “Deviceless RPM” program captures actionable, patient-generated health data that is relevant for the condition(s) of interest. The programs are evidence-based; CareSignal has published 10+ peer-reviewed journal articles and several detailed case studies detailing the operational, clinical, and financial impacts of CareSignal versus the control or previous standard of care.

When a patient responds with symptomatology that falls out of range based on your organization’s established standards of care, CareSignal generates an actionable alert, enabling your care management team to reach out with clinical context.

Note that CareSignal uses only the technology that a patient already owns and understands: text messages or phone calls to cell phones or landline phones, respectively. Additionally CareSignal can offer text messages via FTEU (“free to end user”) so that the text messages do not count against a patient’s limited cell plan.

CareSignal also offers artificial intelligence-driven re-engagement, “CareSignal AI.” This service operates in the background, predicting when a patient will disengage, and enabling CareSignal’s enrollment team to preventatively reach out to re-engage that patient.